medigraphic.com
SPANISH

Salud Pública de México

Instituto Nacional de Salud Pública
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 3

<< Back Next >>

salud publica mex 2019; 61 (3)

The descriptive epidemiology of lung cancer and tobacco control: a global overview 2018

Miranda-Filho A, Piñeros M, Bray F
Full text How to cite this article

Language: English
References: 22
Page: 219-229
PDF size: 1047.77 Kb.


Key words:

lung cancer, epidemiology, tobacco, surveillance.

ABSTRACT

Objective. To present the most recent national estimates of lung cancer burden globally in 185 countries and tobacco smoking prevalence (%) by sex. Materials and methods. Estimates of lung cancer incidence and mortality for 2018 were extracted from the Globocan database; observed incidence, from the last volume of Cancer Incidence in Five Continents, and tobacco prevalence, from the World Health Observatory/WHO database. Results. In 2018, over two million new lung cancer cases and 1.7 million deaths were estimated to occur worldwide, representing 14% of the new cancer cases and 20% of the cancer deaths. Incidence rates showed marked variation between countries. Stable or decreasing incidence rates were predominant among males, while among females increasing rates were common. Conclusion. The continuing rise in lung cancer among women reinforces the need for strengthening implementation of the preventive actions committed to by governments in the WHO Framework Convention for Tobacco Control.


REFERENCES

  1. Globocan 2018 [Internet]. Lyon, France: International Agency for Research on Cancer. c2013- [cited 2018 Sep 23]. Available from: http:// globocan.iarc.fr

  2. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 coun tries. Lancet. 2018;391(10125):1023-75. https://doi.org/10.1016/S0140- 6736(17)33326-3

  3. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monogr Eval Carcinog Risks Hum. 2007;89:1-592.

  4. Peto J. That the effects of smoking should be measured in pack-years: misconceptions 4. Br J Cancer. 2012;107:406-7. https://doi.org/10.1038/ bjc.2012.97

  5. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2008. The MPOWER Package. Geneva: WHO, 2008. Available from: http://www.who.int/tobacco/mpower/gtcr_download/en/index.html

  6. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries: Global Cancer Statistics 2018. CA Cancer J Clin. 2018;68(6):394-424. https://doi.org/10.3322/ caac.21492

  7. Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, Ferlay J (Eds). Cancer Incidence in Five Continents, Vol. XI (electronic version). Lyon: International Agency for Research on Cancer, 2017. Available from: http://ci5.iarc.fr

  8. United Nations Development Programme [Internet]. UNDP; c2017 [cited 2018 Sep 21]. Human Development Programme Index (HDI); [about 2 screens]. Available from: http://hdr.undp.org/en/content/humandevelopment- index-hdi

  9. Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, Ferlay J (Eds). Cancer Incidence in Five Continents Plus (time trends) (electronic version). Lyon: International Agency for Research on Cancer, 2017. Available from: http://ci5.iarc.fr/CI5plus/Default.aspx

  10. World Health Organization Global Health Observatory [internet]. WHO; [cited 2018 Sep 16]. Prevalence of tobacco smoking; [about 1 screen].Available from: https://www.who.int/gho/tobacco/use/en/

  11. World Health Organization. WHO global report on trends in prevalence of tobacco smoking, 2015. Geneva: WHO, 2015. Available from: http:// apps.who.int/iris/bitstream/10665/156262/1/9789241564922_eng.pdf

  12. Segi M, Kurihara M. Cancer mortality for selected sites in 24 countries (1950-1957). 2nd ed. Sendai: Tohoku University of Medicine, 1960.

  13. Thun M, Peto R, Boreham J, Lopez AD. Stages of the cigarette epidemic on entering its second century. Tob Control. 2012;21(2):96-101. https:// doi.org/10.1136/tobaccocontrol-2011-050294

  14. Piñeros M, Sierra MS, Forman D. Descriptive epidemiology of lung cancer and current status of tobacco control measures in Central and South America. Cancer Epidemiol. 2016;44(suppl 1):S90-9. https://doi. org/10.1016/j.canep.2016.03.002

  15. Alonso R, Piñeros M, Laversanne M, Musetti C, Garau M, Barrios E, et al. Lung cancer incidence trends in Uruguay 1990-2014: An age-period-cohort analysis. Cancer Epidemiol. 2018;55:17-22. https://doi.org/10.1016/j. canep.2018.04.012

  16. Guo Y, Zeng H, Zheng R, Li S, Barnett AG, Zhang S, et al. The association between lung cancer incidence and ambient air pollution in China: A spatiotemporal analysis. Environ Res. 2016;144:60-5. https://doi. org/10.1016/j.envres.2015.11.004

  17. Funatogawa I, Funatogawa T, Yano E. Trends in smoking and lung cancer mortality in Japan, by birth cohort, 1949-2010. Bull World Health Organ. 2013;91:332-40. https://doi.org/10.2471/BLT.12.108092

  18. Bray F, Tyczynski JE, Parkin DM. Going up or coming down? The changing phases of the lung cancer epidemic from 1967 to 1999 in the 15 European Union countries. Eur J Cancer. 2004;40(1):96-125. https://doi. org/10.1016/j.ejca.2003.08.005

  19. Cao B, Hill C, Bonaldi C, León ME, Menvielle G, Arwidson P, et al. Cancers attributable to tobacco smoking in France in 2015. Eur J Public Health. 2018;28(4):707-12. https://doi.org/10.1093/eurpub/cky077

  20. World Health Organization. Global action plan for the prevention and control of noncommunicable diseases: 2013-2020. Geneva: WHO, 2013. Available from: http://apps.who.int/iris/bitstre am/10665/94384/1/9789241506236_eng.pdf

  21. Dubray J, Schwartz R, Chaiton M, O’Connor S, Cohen JE. The effect of MPOWER on smoking prevalence. Tob Control. 2015;24(6):540-2. https:// doi.org/10.1136/tobaccocontrol-2014-051834

  22. Jha P. Avoidable global cancer deaths and total deaths from smoking. Nat Rev Cancer. 2009;9:655-64. https://doi.org/10.1038/nrc2703




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

salud publica mex. 2019;61